SORBS1 gene, a new candidate for diabetic nephropathy: results from a multi-stage genome-wide association study in patients with type 1 diabetes
Marine Germain(Inserm), Samy Hadjadj(Université de Poitiers), Per‐Henrik Groop(University of Helsinki), Iiro Toppila(University of Helsinki), Lasse Folkersen(Karolinska Institutet), Jan Skupień(Harvard University), Mete Civelek(University of California, Los Angeles), Hans‐Henrik Parving(Aarhus University), Yi-An Ko(University of Pennsylvania), Marcus G. Pezzolesi(University of Utah), Niina Sandholm(University of Helsinki), Katalin Suszták(Penn Center for AIDS Research), Ronan Roussel(Lyon 1 Université), Amy Jayne McKnight(Queen's University Belfast), Lise Tarnow(Steno Diabetes Centers), David‐Alexandre Trégouët(Université de Bordeaux), Peter Rossing(Steno Diabetes Centers), Michel Marre(Centre National de la Recherche Scientifique), Alexander P. Maxwell, Nóra Ledó(Semmelweis University), Maria Lajer(Steno Diabetes Centers), Carol Forsblom(University of Helsinki)
Cited by 49
Related Papers
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
|New England Journal of Medicine|2008|7.4k
Dapagliflozin in Patients with Chronic Kidney Disease
|New England Journal of Medicine|2020|5.2k
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2020|2.6k
Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
|Diabetes Care|2022|1.9k
Large-scale association analysis identifies new risk loci for coronary artery disease
|Nature Genetics|2012|1.7k